Drug - Astagraf XL (tacrolimus) [Astellas Pharmaceuticals]
Therapeutic area - Immunosuppresant
- Patient has received a kidney transplant AND
- Patient has documented non-compliance with generic tacrolimus
34 per 34 days
ASTAGRAF XL (tacrolimus extended-release capsules) is approved for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction.
MHCP Provider Call Center 651-431-2700 or 800-366-5411